Clinical Trials Logo

Clinical Trial Summary

Kidney transplantation (KT) is the most effective treatment for end-stage renal disease, offering improved quality of life and long-term survival. However, predicting transplant survival and assessing prognostic factors is complex due to the multifaceted nature of patient variables and individualized treatments. Traditional methods have fallen short in their predictive accuracy. This study aims to develop machine learning algorithms capable of parsing extensive clinical data to identify key prognostic indicators that can potentially forecast survival rates for KT recipients. By incorporating baseline characteristics of donors and recipients, the model strives to unearth patterns linking donor and recipient profiles, thereby offering insights into modifiable factors that could influence postoperative outcomes. The goal is to provide a tool that aids clinicians in improving the prognosis and quality of life for KT recipients.


Clinical Trial Description

Kidney transplantation (KT) is the most effective treatment modality for end-stage renal disease (ESRD), offering patients the opportunity to ahieve improved quality of life and long-term survival. Advances in surgical techniques and immunosuppressive regimens have substantially decreased immediate postoperative complications and acute rejection episodes. Considering that KT is the most frequently performed organ transplantation, improving the longevity of transplant survival could benefit many individuals. The efficacy of KT is often gauged by graft function, which is a critical determinant of the graft's long-term survival and a key metric in evaluating transplant success. While post-transplant graft function is influenced by a spectrum of variables-from the characteristics of donors and recipients to immunosuppressive strategies-this complexity presents challenges in forecasting outcomes, particularly over the long term. Traditional methods, such as the kidney donor risk index (KDRI) and Cox regression analyses, have fallen short in their predictive accuracy. The prediction of transplant survival and the assessment of prognostic factors are complex due to the multifaceted nature of patient variables and the individualization of perioperative treatments. Yet, with the rise of machine learning and advanced computational analytics, researchers are now poised to decode the intricacies of data with clinical significance, potentially transforming patient care post-transplantation. The integration of deep learning algorithms into clinical practice in the field of transplantation is a relatively nascent area but is rapidly gaining traction. This study aims to develop machine learning algorithms capable of parsing extensive clinical data to pinpoint key prognostic indicators which can potentially forecast survival rates for KT recipients. By incorporating baseline characteristics of both donors and recipients, the present model strives to unearth patterns linking donor and recipient profiles, thereby offering insights into modifiable factors that could influence postoperative outcomes. Through this, we seek to provide a tool that aids clinicians in improving the prognosis and quality of life for KT recipients. ;


Study Design


Related Conditions & MeSH terms

  • Kidney Transplant Failure and Rejection

NCT number NCT06394596
Study type Observational
Source Asan Medical Center
Contact
Status Completed
Phase
Start date January 1, 2023
Completion date February 1, 2024

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04057742 - AlloSure for the Monitoring of Antibody Mediated Processes After Kidney Transplantation
Recruiting NCT03465397 - Individualization of the Immunological Risk Based on Selective Biomarkers in Living-donor Renal Recipients Phase 4
Completed NCT03437577 - Comparison of the Cognitive and Motor Effects of Treatment Between an Immediate- and Extended-release Tacrolimus (Envarsus® XR) Based Immunosuppression Regimen in Kidney Transplant Recipients Phase 1/Phase 2
Not yet recruiting NCT05282966 - Assessment of QSantâ„¢ for Underlying Allograft Rejection
Recruiting NCT04388930 - The Microbiota in Kidney Donation and Transplantation
Completed NCT03611621 - A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation
Recruiting NCT05397821 - Pediatric Kidney Transplantation, Ureteroneocystostomy Techniques
Completed NCT04019353 - Cf-DNA Assay During Treatment of Acute Rejection
Recruiting NCT05806749 - Immunological Tolerance in Patients With Mismatched Kidney Transplants Phase 1
Recruiting NCT04936282 - Treatment of Early Borderline Lesions in Low Immunological Risk Kidney Transplant Patients (TRAINING) Phase 4
Enrolling by invitation NCT05285878 - Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation Phase 2
Recruiting NCT04526431 - Tacrolimus Pharmacokinetic Subpopulations
Active, not recruiting NCT03511560 - Envarsus on the Effect of Total Tacrolimus Dose/Trough Level Ratio on Renal Function (eGFR) in Kidney Transplantation Phase 4
Recruiting NCT03438773 - Prospective Pilot Feasibility Study Comparing Envarsus Once-a-day to Tacrolimus Twice-a-day Immunosuppressive Regimen on Drug Bioavailability in Hispanic First Time Kidney Transplant Recipients Phase 1
Completed NCT05388955 - Risk Assessment Tool for Graft Survival in Pediatric Kidney Transplantation
Completed NCT04413916 - MiRNA in Kidney Transplantation: Association With Kidney Graft Function and Disease Process
Completed NCT03466775 - Anti-Angiotensin II Type 1 Receptor Antibodies and Kidney Transplant Outcomes N/A
Active, not recruiting NCT04733131 - Long-term Outcomes After Conversion to Belatacept
Active, not recruiting NCT03380962 - Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant Phase 1/Phase 2
Active, not recruiting NCT04154267 - Protocol Biopsies in High-risk Renal Transplant Recipients N/A